| pubmed-article:9480093 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C0019080 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C0031666 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C0022885 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C0444706 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C1254881 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C1739089 | lld:lifeskim |
| pubmed-article:9480093 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:9480093 | pubmed:dateCreated | 1998-2-25 | lld:pubmed |
| pubmed-article:9480093 | pubmed:abstractText | The influence of platelet-specific and HLA antibodies on primary hemostasis was investigated by the in vitro bleeding test (IVBT). Seven of 12 plasmas with HPA-1a (PLA1) antibodies and two with antibodies against glycoprotein Ib/IX significantly inhibited the IVBT of normal cross-match-positive donor blood. This correlated with an increase of GMP-140 on the platelets determined by flow cytometry. Therefore the inhibition of the IVBT was interpreted to be due to rapid platelet activation by platelet-specific antibodies followed by an irreversible loss of function. In contrast, with HLA antibodies neither activation nor inhibition of the platelet function could be proven. | lld:pubmed |
| pubmed-article:9480093 | pubmed:language | ger | lld:pubmed |
| pubmed-article:9480093 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9480093 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9480093 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9480093 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9480093 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9480093 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9480093 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9480093 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9480093 | pubmed:issn | 1023-2028 | lld:pubmed |
| pubmed-article:9480093 | pubmed:author | pubmed-author:FellerKK | lld:pubmed |
| pubmed-article:9480093 | pubmed:author | pubmed-author:KretschmerVV | lld:pubmed |
| pubmed-article:9480093 | pubmed:author | pubmed-author:KiefelVV | lld:pubmed |
| pubmed-article:9480093 | pubmed:author | pubmed-author:LEVYJ IJI | lld:pubmed |
| pubmed-article:9480093 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9480093 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:9480093 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9480093 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9480093 | pubmed:pagination | 221-4 | lld:pubmed |
| pubmed-article:9480093 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:meshHeading | pubmed-meshheading:9480093-... | lld:pubmed |
| pubmed-article:9480093 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:9480093 | pubmed:articleTitle | [Effect of HPA-1a(PLA1) and HLA antibodies on platelet function, measured with the in vitro bleeding test]. | lld:pubmed |
| pubmed-article:9480093 | pubmed:affiliation | Abteilung für Transfusionsmedizin und Gerinnungsphysiologie, Universitätsklinikum, Marburg. | lld:pubmed |
| pubmed-article:9480093 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9480093 | pubmed:publicationType | English Abstract | lld:pubmed |
